Home
About Opexa
About Opexa
Management Team
Board of Directors
Scientific Advisory Board
Facility
Contact Us
Tcelna®
Tcelna® Description
TERMS Phase 2b Overview
MS Overview
Publications
OPX-212
OPX-212 Description
Neuromyelitis Optica
Clinical Trials
Abili-T Clinical Study for Secondary Progressive Multiple Sclerosis Overview
ImmForm® Clinical Management Tool
Technology
T-cell Platform
Opexa cGMP Manufacturing
Pipeline
News & Resources
Multimedia
Press Releases
Webcasts
Publications
Conference & Meeting Presentations
Investor Relations
Why Invest
Press Releases
Events & Presentations
Stock Information
SEC Filings
Financial Reports
Corporate Governance
Analyst Coverage
Investor FAQs
Careers
Working at Opexa
Open Positions
How to Apply
Living in The Woodlands
Contact Us
Contact Us
Home
/
News & Resources
/
Press Releases
News & Resources
Multimedia
Press Releases
Webcasts
Publications
Conference & Meeting Presentations
Multimedia
Press Releases
Webcasts
Publications
Conference & Meeting Presentations
Quick Links
About Opexa
Tcelna®
Clinical Trials
Contact Us
Email Alerts
Email Address
*
Mailing Lists
*
Releases
SEC Filings
Presentation
Events
Enter the code shown above.
Unsubscribe from email alerts
Normal
Press Releases
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
12/09/2011
Opexa Therapeutics to Present at the Oppenheimer 22nd Annual Healthcare Conference
11/14/2011
Opexa Announces Publication in Multiple Sclerosis Journal of Tovaxin® Phase IIb Clinical Trial Results
11/11/2011
Opexa Therapeutics to Present at the Lazard Capital Markets 8th Annual Healthcare Conference
11/08/2011
Opexa's Tovaxin® for the Treatment of Multiple Sclerosis Granted Fast Track Designation by FDA
11/04/2011
Opexa Therapeutics Reports Third Quarter 2011 Financial Results and Provides Corporate Update
11/02/2011
Opexa Elects Gail Maderis to Board of Directors
09/19/2011
Opexa’s CEO Invited to Present at Two Cell Therapy Forums in Asia During September, 2011
09/12/2011
Dr. Mark Freedman to Join Opexa's Scientific Advisory Board
09/07/2011
Opexa to Present at the Rodman & Renshaw Annual Global Investment Conference - Healthcare on September 13, 2011
08/11/2011
Opexa Therapeutics Reports Second Quarter 2011 Financial Results and Provides Corporate Update
06/28/2011
Opexa Executes Service Agreement with Blood Group Alliance, Inc.
06/02/2011
Opexa Initiates Discussions with Health Canada in Pre-CTA Meeting
05/17/2011
Opexa Executes Strategic Service Agreement with the American Red Cross
05/06/2011
Opexa Therapeutics Reports First Quarter 2011 Financial Results
04/15/2011
Opexa Presents Tovaxin® Data at American Academy of Neurology 2011 Annual Meeting
03/23/2011
Opexa to Present Tovaxin® Data at 2011 American Academy of Neurology Annual Meeting
03/08/2011
Opexa Therapeutics Reports Year End 2010 Financial Results and Provides Corporate Update
02/22/2011
Opexa CEO Invited as Keynote Speaker at Cell Therapy Conference in Beijing, China
02/09/2011
Opexa to Present at the 13th Annual BIO CEO & Investor Conference on February 14, 2011
02/08/2011
Opexa Therapeutics, Inc. Announces Pricing of Public Offering of Common Stock and Warrants
02/07/2011
Opexa Therapeutics, Inc. Announces Proposed Public Offering of Common Stock and Warrants
01/05/2011
Opexa Completes Successful Meetings with FDA to Pursue Phase 3 Clinical Study for Tovaxin® in Multiple Sclerosis
© 2013 Opexa Therapeutics, Inc. All Rights Reserved.
Privacy Policy
Terms of Use
Powered By Q4 Web Systems
4.1.3.41